NAD+
Nicotinamide Adenine Dinucleotide
The cellular fuel molecule that declines 50% by middle age
NAD+ is a coenzyme found in every living cell, essential for energy metabolism, DNA repair, and sirtuin activation. Levels decline significantly with age, driving interest in supplementation via IV, injection, and precursors.

Admin routes
Intravenous, Subcutaneous, Oral (NMN/NR precursors)
Popularity
High
Side effects
Generally mild
AU vendors
3 rated
โKey benefits
๐What to expect
Immediate energy boost; mental clarity (can be intense)
Improved energy levels and reduced fatigue
Better sleep quality; improved cellular energy
Sustained metabolic and cognitive improvements
Based on community reports and published research. Individual results vary significantly.
๐Dosing protocols
IV infusion (clinical)
250โ500 mg
1โ2 times per week
4โ8 week courses
Subcutaneous injection
50โ100 mg
Daily or every other day
Ongoing or cycled
Oral NMN precursor
250โ1000 mg NMN daily
Once daily (morning)
Ongoing
Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.
Research status|Extensive preclinical data - human clinical trials ongoing
Overview
NAD+ (Nicotinamide Adenine Dinucleotide) is not a peptide in the traditional sense - it's a coenzyme present in all living cells that is essential for hundreds of metabolic processes. It plays a critical role in converting food to energy (ATP production), activating sirtuins (longevity-associated proteins), supporting DNA repair via PARP enzymes, and maintaining circadian rhythm. NAD+ levels decline approximately 50% between ages 40 and 60, correlating with metabolic dysfunction, neurodegeneration, and the visible signs of aging. This decline has driven enormous interest in NAD+ restoration through IV infusions, subcutaneous injection, and oral precursors like NMN and NR.
โ๏ธHow it works
NAD+ functions as an electron carrier in mitochondrial energy production (oxidative phosphorylation) and as a substrate for three families of enzymes: sirtuins (SIRT1-7), PARPs (DNA repair enzymes), and CD38 (an immune cell enzyme that consumes NAD+). Sirtuins regulate gene expression, inflammation, and metabolic function but require NAD+ to function. As NAD+ declines with age, sirtuin activity decreases, contributing to cellular dysfunction. Supplementation aims to restore NAD+ levels, reactivating these protective pathways. CD38, which increases with age and chronic inflammation, is a major driver of NAD+ depletion.
โกSide effects
๐ Research history
NAD+ first discovered by Arthur Harden and William John Young
Guarente lab discovers sirtuins require NAD+ for activity
David Sinclair publishes landmark NAD+ aging paper in Cell
Multiple clinical trials for NAD+ precursors (NR, NMN) underway
IV NAD+ clinics proliferate worldwide; debate on optimal delivery continues
๐ชRated vendors (Australia)
View all โPeptides Collective
Perth, WA ยท 99%+ (third-party verified) purity ยท 1โ2 days (Perth), 2โ4 days (national)
peptidescollective.health โLotusLabs
Australia ยท 99%+ (HPLC and mass spectrometry) purity ยท Same-day dispatch, 2โ3 days delivery
lotuslabs.com.au โAustralian Peptides
Australia ยท 99%+ (US third-party tested) purity ยท 1โ3 days (Express Post)
australianpeptides.com โVendor ratings are based on community feedback and are not endorsements. Always verify third-party certificates of analysis (CoA) and check current Australian regulations before purchasing.
IV vs injection vs oral
IV NAD+ infusions deliver the compound directly to the bloodstream at high doses (250โ500 mg) but take 2โ4 hours due to the flushing and discomfort caused by rapid infusion. They are the most expensive option ($300โ800 AUD per session). Subcutaneous NAD+ injection is faster and cheaper, delivering 50โ100 mg in seconds, though bioavailability studies are limited. Oral precursors (NMN, NR) are the most accessible and affordable option - NMN is converted to NAD+ inside cells. A 2024 study showed oral NMN at 1000 mg/day increased blood NAD+ levels by 40โ50% over 60 days.
The NAD+ decline
NAD+ levels peak in youth and decline steadily through adulthood. By age 50, levels are roughly half of what they were at 20. This decline is driven by increased activity of CD38 (an enzyme that breaks down NAD+), reduced synthesis, and increased demand from DNA repair processes. The decline correlates with mitochondrial dysfunction, reduced sirtuin activity, and many hallmarks of aging. Researchers like Dr. David Sinclair (Harvard) have popularised the concept that restoring NAD+ could slow or reverse aspects of biological aging.
NMN vs NR
NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) are both NAD+ precursors available as oral supplements. NMN is one step closer to NAD+ in the biosynthetic pathway. NR has more published human clinical trial data (ChromaDex's Tru Niagen). Both effectively raise NAD+ levels. NMN is currently more popular in the longevity community, partly due to David Sinclair's advocacy. In Australia, NMN was briefly classified as a controlled substance in 2024 before being reclassified - check current TGA status before purchasing.
References
- [1]Yoshino J, et al. "NAD+ intermediates: the biology and therapeutic potential." Cell Metabolism, 2018.
- [2]Rajman L, et al. "Therapeutic potential of NAD-boosting molecules." Cell Metabolism, 2018.
- [3]Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels." NPJ Aging, 2022.
- [4]Covarrubias AJ, et al. "NAD+ metabolism and its roles in cellular processes during ageing." Nature Reviews Molecular Cell Biology, 2021.
Frequently asked questions
Related peptides
Need to calculate your dose?
Use our free reconstitution calculator to work out syringe units for NAD+.
Open CalculatorDisclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Australian regulations classify many peptides as Schedule 4 (prescription-only) substances. Check current TGA guidelines before purchasing.